Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase

Molecular Biology of the Cell

Volumn 17, Issue 3, 2006, Pages 1141-1153

  Balan, Vitaly ^a   Leicht, Deborah T ^a   Zhu, Jun ^b   Balan, Karina ^a   Kaplun, Alexander ^a   Singh Gupta, Vinita ^a   Qin, Jun ^c   Ruan, Hong ^d   Comb, Michael J ^d   Tzivion, Guri ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CELL SIGNALING TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPEPTIDE; RAF PROTEIN; RAS PROTEIN; SERINE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PHOSPHO-SPECIFIC; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEEDBACK, BIOCHEMICAL; GENE EXPRESSION; MAP KINASE KINASE KINASES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; SERINE;

ANIMALIA;

EID: 33644856401     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-12-1123     Document Type: Article

References (56)

1. Abraham, D., Podar, K., Pacher, M., Kubicek, M., Welzel, N., Hemmings, B. A., Dilworth, S. M., Mischak, H., Kolch, W., and Baccarini, M. (2000). Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275, 22300-22304.
2. Alessandrini, A., Greulich, H., Huang, W., and Erikson, R. L. (1996). Mek1 phosphorylation site mutants activate Raf-1 in NIH 3T3 cells. J. Biol. Chem. 271, 31612-31618.
3. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., and Saltiel, A. R. (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 27489-27494.
4. Anderson, N. G., Li, P., Marsden, L. A., Williams, N., Roberts, T. M., and Sturgill, T. W. (1991). Raf-1 is a potential substrate for mitogen-activated protein kinase in vivo. Biochem. J. 277, 573-576.
5. Avruch, J., Khokhlatchev, A., Kyriakis, J. M., Luo, Z., Tzivion, G., Vavvas, D., and Zhang, X. F. (2001). Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Prog. Horm. Res. 56, 127-155.
6. Avruch, J., Zhang, X. F., and Kyriakis, J. M. (1994). Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19, 279-283.
7. Boyle, W. J., van der Geer, P., and Hunter, T. (1991). Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201, 110-149.
8. Chang, L., and Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature 410, 37-40.
9. Chong, H., Lee, J., and Guan, K. L. (2001). Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J. 20, 3716-3727.
10. Chong, H., Vikis, H. G., and Guan, K. L. (2003). Mechanisms of regulating the Raf kinase family. Cell Signal. 15, 463-469.
11. Davies, H., et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
12. Dhillon, A. S., and Kolch, W. (2002). Untying the regulation of the Raf-1 kinase. Arch. Biochem. Biophys. 404, 3-9.
13. Dhillon, A. S., Meikle, S., Yazici, Z., Eulitz, M., and Kolch, W. (2002). Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21, 64-71.
14. Dougherty, M. K., Muller, T., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., and Morrison, D. K. (2005). Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17, 215-224.
15. Dumaz, N., and Marais, R. (2005). Raf phosphorylation: one step forward and two steps back. Mol. Cell 17, 164-166.
16. Hagemann, C., and Rapp, U. R. (1999). Isotype-specific functions of Raf kinases. Exp. Cell Res. 253, 34-46.
17. Hamilton, M., Liao, J., Cathcart, M. K., and Wolfman, A. (2001). Constitutive association of c-N-Ras with c-Raf-1 and PKC epsilon in latent signaling modules. J. Biol. Chem. 276, 29079-29090.
18. Hekman, M., Fischer, A., Wennogle, L. P., Wang, Y. K., Campbell, S. L., and Rapp, U. R. (2005). Novel C-Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation. FEBS Lett. 579, 464-468.
19. Herrera, R., and Sebolt-Leopold, J. S. (2002). Unraveling the complexities of the Raf/MAP kinase pathway for pharmacological intervention. Trends Mol. Med. 8, S27-31.
20. Huang, W., and Erikson, R. L. (1994). Constitutive activation of Mek1 by mutation of serine phosphorylation sites. Proc. Natl. Acad. Sci. USA 91, 8960-8963.
21. Jaumot, M., and Hancock, J. F. (2001). Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20, 3949-3958.
22. Kerkhoff, E., and Rapp, U. R. (2001). The Ras-Raf relationship: an unfinished puzzle. Adv. Enzyme Regul. 41, 261-267.
23. King, A. J., Sun, H., Diaz, B., Barnard, D., Miao, W., Bagrodia, S., and Marshall, M. S. (1998). The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396, 180-183.
24. Kolch, W. (2000). Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351, 289-305.
25. Kyriakis, J. M., Force, T. L., Rapp, U. R., Bonventre, J. V., and Avruch, J. (1993). Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase. J. Biol. Chem. 268, 16009-16019.
26. Laird, A. D., Morrison, D. K., and Shalloway, D. (1999). Characterization of Raf-1 activation in mitosis. J. Biol. Chem. 274, 4430-4439.
27. Liebmann, C. (2001). Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal. 13, 777-785.
28. Luo, K. X., Hurley, T. R., and Sefton, B. M. (1991). Cyanogen bromide cleavage and proteolytic peptide mapping of proteins immobilized to membranes. Methods Enzymol. 201, 149-152.
29. Luo, Z., Tzivion, G., Belshaw, P. J., Vavvas, D., Marshall, M., and Avruch, J. (1996). Oligomerization activates c-Raf-1 through a Ras-dependent mechanism. Nature 383, 181-185.
30. Lyons, J. F., Wilhelm, S., Hibner, B., and Bollag, G. (2001). Discovery of a novel Raf kinase inhibitor. Endocr. Relat. Cancer 8, 219-225.
31. Marais, R., Light, Y., Mason, C., Paterson, H., Olson, M. F., and Marshall, C. J. (1998). Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by PKC. Science 280, 109-112.
32. Mason, C. S., Springer, C. J., Cooper, R. G., Superti-Furga, G., Marshall, C. J., and Marais, R. (1999). Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18, 2137-2148.
33. Mercer, K. E., and Pritchard, C. A. (2003). Raf proteins and cancer: B-Raf is identified as a mutational target. Biochim. Biophys. Acta 1653, 25-40.
34. Morrison, D. K., Heidecker, G., Rapp, U. R., and Copeland, T. D. (1993). Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268, 17309-17316.
35. Murakami, M. S., and Morrison, D. K. (2001). Raf-1 without MEK? Sci. STKE 2001, E30
36. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B. E., Karandikar, M., Berman, K., and Cobb, M. H. (2001). Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183.
37. Porter, A. C., and Vaillancourt, R. R. (1998). Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17, 1343-1352.
38. Qin, J., and Zhang, X. (2002). Identification of in vivo protein phosphorylation sites with mass spectrometry. Methods Mol. Biol. 194, 211-221.
39. Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., Jr., and Stephenson, J. R. (1983). Structure and biological activity of v-raf, a unique Oncogene transduced by a retrovirus. Proc. Natl. Acad. Sci. USA 80, 4218-4222.
40. Rommel, C., Clarke, B. A., Zimmermann, S., Nunez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D., and Glass, D. J. (1999). Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1741.
41. Shen, Y. H., Godlewski, J., Bronisz, A., Zhu, J., Comb, M. J., Avruch, J., and Tzivion, G. (2003a). Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. Mol. Biol. Cell 34, 4721-4733.
42. Shen, Y. H., Godlewski, J., Zhu, J., Sathyanarayana, P., Leaner, V., Birrer, M. J., Rana, A., and Tzivion, G. (2003b). Cross-talk between JNK/SAPK and ERK/MAPK pathways: sustained activation of JNK blocks ERK activation by mitogenic factors. J. Biol. Chem. 278, 26715-26721.
43. Sidovar, M. F., Kozlowski, P., Lee, J. W., Collins, M. A., He, Y., and Graves, L. M. (2000). Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase. J. Biol. Chem. 275, 28688-28694.
44. Tzivion, G., and Avruch, J. (2002). 14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation. J. Biol. Chem. 277, 3061-3064.
45. Tzivion, G., LuO, Z., and Avruch, J. (1998). A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394, 88-92.
46. Tzivion, G., Shen, Y. H., and Zhu, J. (2001). 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20, 6331-6338.
47. Wan, P. T., et al. (2004). Mechanism of activation of the RAF-EBUC signaling pathway by oncogenic mutations of B-RAF. Cell 116, 855-867.
48. Weinstein-Oppenheimer, C. R., Blalock, W. L., Steelman, L. S., Chang, F., and McCubrey, J. A. (2000). The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors. Pharmacol. Ther. 88, 229-279.
49. Wellbrock, C., Karasarides, M., and Marais, R. (2004a). The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5, 875-885.
50. Wellbrock, C., Ogilvie, L., Hedley, D., Karasarides, M., Martin, J., Niculescu-Duvaz, D., Springer, C. J., and Marais, R. (2004b). V599EB-RAF is an oncogene in melanocytes. Cancer Res. 64, 2338-2342.
51. Yip-Schneider, M. T., Miao, W., Lin, A., Barnard, D. S., Tzivion, G., and Marshall, M. S. (2000). Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem. J. 351, 151-159.
52. Zhang, B. H., and Guan, K. L. (2001). Regulation of the Raf kinase by phosphorylation. Exp. Lung Res. 27, 269-295.
53. Zhang, Y., Yao, B., Delikat, S., Bayoumy, S., Lin, X. H., Basu, S., McGinley, M., Chan-Hui, P. Y., Lichenstein, H., and Kolesnick, R. (1997). Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89, 63-72.
54. Zhu, J., Balan, V., Bronisz, A., Balan, K., Sun, H., Leicht, D. T., Luo, Z., Qin, J., Avruch, J., and Tzivion, G. (2005). Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding. Mol. Biol. Cell 16, 4733-4744.
55. Zimmermann, S., and Moelling, K. (1999). Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
56. Zimmermann, S., Rommel, C., Ziogas, A., Lovric, J., Moelling, K., and Radziwill, G. (1997). MEK1 mediates a positive feedback on Raf-1 activity independently of Ras and Src. Oncogene 15, 1503-1511.